# Sirona Biochem Corp. (SRBCF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SRBCF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 15.5K | $ -2.07M | $ -1.82M | $ 3.32M | $ -3.46M |
| 2023 | $ 36.1K | $ -2.64M | $ -1.82M | $ 2.18M | $ -2.51M |
| 2022 | $ 925.7K | $ -3.82M | $ -2.34M | $ 470.2K | $ 214.5K |
| 2021 | $ 523.5K | $ -3.59M | $ -2.46M | $ 850.6K | $ -97.0K |
| 2020 | $ 127.0K | $ -4.94M | $ -2.58M | $ 1.24M | $ 47.4K |
| 2019 | $ 186.7K | $ -5.48M | $ -4.29M | $ 1.55M | $ 2.19M |
| 2018 | $ 1.57M | $ -1.57M | $ -805.0K | $ 2.51M | $ -2.26M |
| 2017 | $ 6.9K | $ -5.60M | $ -3.36M | $ 2.69M | $ -2.04M |
| 2016 | $ 461.2K | $ -3.81M | $ -2.87M | $ 968.6K | $ 1.56M |
| 2015 | $ 10.4K | $ -4.60M | $ -3.78M | $ 1.40M | $ 2.35M |
| 2014 | $ 274.1K | $ -4.65M | $ -2.76M | $ 673.5K | $ 1.79M |
| 2013 | $ 0 | $ -3.73M | $ -3.50M | $ 515.5K | $ 2.24M |
| 2012 | $ 0 | $ -4.04M | $ -3.01M | $ 93.1K | $ 1.70M |
| 2011 | $ 0 | $ -3.45M | $ -4.86M | $ 92.5K | $ 2.71M |
| 2010 | $ 0 | $ -1.49M | $ -1.18M | $ 0 | $ 684.1K |
| 2009 | $ 0 | $ -1.74M | $ -2.23M | $ 0 | $ 479.7K |
| 2008 | $ 0 | $ -140.7K | $ -227.2K | $ 0 | $ 1.03M |
| 2007 | $ 0 | $ -319.9K | $ -124.3K | $ 0 | $ 1.13M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.96 |
| Liabilities / Eq | -1.23 |
| Current Ratio | 0.34 |

## Other views

- [Metrics](https://sponda.capital/en/SRBCF.md)
- [Charts](https://sponda.capital/en/SRBCF/charts.md)
- [Compare](https://sponda.capital/en/SRBCF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-23.